Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Oncology (Williston Park, N.Y.)|March 28, 1998
Taxanes in adjuvant and neoadjuvant therapies for breast cancerJ O'Leary, M Volm, C Wasserheit, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Preclinical pharmacokinetics and stability of isophosphoramide mustardJ J Zheng, K K Chan, F MuggiaAnticancer Research|March 25, 2010
Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancerN Seetharamu, E Kim, H Hochster, et al.AJR. American Journal of Roentgenology|September 1, 1996
Saline MR peritoneographyG R Magre, M Terk, P Colletti, et al.Ecancermedicalscience|January 26, 2012
Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligoY Yuan, S J Orlow, J Curtin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1984
Malignant mesothelioma of the tunica vaginalis testisK Antman, S Cohen, N V Dimitrov, et al.Cancer Treatment Reports|November 1, 1979
Two-stage plans for patient accrual in phase II cancer clinical trialsY J Lee, M Staquet, R Simon, et al.Ecancermedicalscience|October 12, 2012
Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinomaS Lewin, D Dezube, Ak Guddati, et al.Ecancermedicalscience|January 26, 2012
Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriersA Dilawari, J Cangiarella, J Smith, et al.American Journal of Clinical Oncology|April 1, 1983
Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu)P F Engstrom, J M MacIntyre, H O Douglass, et al.Pageof 6